The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, C. S.
Right arrow Articles by Mescher, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, C. S.
Right arrow Articles by Mescher, M. F.
The Journal of Immunology, 1999, 163: 2561-2567.
Copyright © 1999 by The American Association of Immunologists

Adjuvant Effect of IL-12: Conversion of Peptide Antigen Administration from Tolerizing to Immunizing for CD8+ T Cells In Vivo1

Clint S. Schmidt and Matthew F. Mescher2

Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455

CD8+ T cells from TCR transgenic 2C mice, specific for SIYRYYGL peptide bound to H-2Kb, were adoptively transferred into C57BL/6 recipients to allow monitoring of their location, numbers, and phenotype upon peptide challenge. Recipients were primed by s.c. injection of SIYRYYGL alone or with CFA or IL-12, and the transferred cells then tracked by flow cytometry using the 1B2 mAb specific for the 2C TCR. Peptide alone induced a transient and weak expansion of 1B2+ cells in the draining lymph nodes (DLN) by day 3, but these cells were tolerant to secondary peptide challenge. In contrast, priming with CFA/peptide resulted in a large clonal expansion of 1B2+ cells in DLN by day 3, and the cells exhibited a CD25highCD44high phenotype, blast transformation, and lytic effector function. By day 5, 1B2+ cell numbers decreased in the DLN and increased in the spleen and blood. 1B2+ cells with a memory phenotype persisted through day 60 in the DLN, spleen, and blood and responded to secondary peptide challenge. Immunization with peptide, along with IL-12, mimicked the adjuvant effects of CFA with respect to phenotype, clonal expansion, effector function, and establishment of memory. IL-12 was not unique in providing this adjuvant effect however, since CFA/peptide immunization of IL-12-deficient recipient mice also resulted in 1B2+ T cell activation and clonal expansion. Thus, CFA or IL-12 can enhance Ag-specific CD8+ T cell responses to peptide, demonstrating that an inflammatory cytokine(s) can support activation and prevent tolerance induction.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
C. D. Hammerbeck and M. F. Mescher
Antigen Controls IL-7R{alpha} Expression Levels on CD8 T Cells during Full Activation or Tolerance Induction
J. Immunol., February 15, 2008; 180(4): 2107 - 2116.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J.-B. Lee, K.-A Lee, and J. Chang
Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation
Int. Immunol., September 6, 2007; (2007) dxm072v1.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
V. A. Love, N. Grabie, P. Duramad, G. Stavrakis, A. Sharpe, and A. Lichtman
CTLA-4 Ablation and Interleukin-12 Driven Differentiation Synergistically Augment Cardiac Pathogenicity of Cytotoxic T Lymphocytes
Circ. Res., August 3, 2007; 101(3): 248 - 257.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Curtsinger, M. Y. Gerner, D. C. Lins, and M. F. Mescher
Signal 3 Availability Limits the CD8 T Cell Response to a Solid Tumor
J. Immunol., June 1, 2007; 178(11): 6752 - 6760.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Murugaiyan, R. Agrawal, G. C. Mishra, D. Mitra, and B. Saha
Differential CD40/CD40L Expression Results in Counteracting Antitumor Immune Responses
J. Immunol., February 15, 2007; 178(4): 2047 - 2055.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Anderson, K. Shafer-Weaver, N. M. Greenberg, and A. A. Hurwitz
Tolerization of Tumor-Specific T Cells Despite Efficient Initial Priming in a Primary Murine Model of Prostate Cancer
J. Immunol., February 1, 2007; 178(3): 1268 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Koido, E. Hara, S. Homma, A. Torii, M. Mitsunaga, S. Yanagisawa, Y. Toyama, H. Kawahara, M. Watanabe, S. Yoshida, et al.
Streptococcal Preparation OK-432 Promotes Fusion Efficiency and Enhances Induction of Antigen-Specific CTL by Fusions of Dendritic Cells and Colorectal Cancer Cells
J. Immunol., January 1, 2007; 178(1): 613 - 622.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Murugaiyan, R. Agrawal, G. C. Mishra, D. Mitra, and B. Saha
Functional Dichotomy in CD40 Reciprocally Regulates Effector T Cell Functions
J. Immunol., November 15, 2006; 177(10): 6642 - 6649.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
N. Sanarico, A. Ciaramella, A. Sacchi, D. Bernasconi, P. Bossu, F. Mariani, V. Colizzi, and S. Vendetti
Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response
J. Leukoc. Biol., September 1, 2006; 80(3): 555 - 562.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Curtsinger, D. C. Lins, C. M. Johnson, and M. F. Mescher
Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis
J. Immunol., October 1, 2005; 175(7): 4392 - 4399.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Markiewicz, L. N. Carayannopoulos, O. V. Naidenko, K. Matsui, W. R. Burack, E. L. Wise, D. H. Fremont, P. M. Allen, W. M. Yokoyama, M. Colonna, et al.
Costimulation through NKG2D Enhances Murine CD8+ CTL Function: Similarities and Differences between NKG2D and CD28 Costimulation
J. Immunol., September 1, 2005; 175(5): 2825 - 2833.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Li, J. S. Heuser, S. D. Kosanke, M. Hemric, and M. W. Cunningham
Protection against Experimental Autoimmune Myocarditis Is Mediated by Interleukin-10-Producing T Cells that Are Controlled by Dendritic Cells
Am. J. Pathol., July 1, 2005; 167(1): 5 - 15.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. A. Filatenkov, E. L. Jacovetty, U. B. Fischer, J. M. Curtsinger, M. F. Mescher, and E. Ingulli
CD4 T Cell-Dependent Conditioning of Dendritic Cells to Produce IL-12 Results in CD8-Mediated Graft Rejection and Avoidance of Tolerance
J. Immunol., June 1, 2005; 174(11): 6909 - 6917.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Curtsinger, J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher
Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation
J. Immunol., April 15, 2005; 174(8): 4465 - 4469.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. O. Valenzuela, C. D. Hammerbeck, and M. F. Mescher
Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells
J. Immunol., January 15, 2005; 174(2): 600 - 604.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Reich-Zeliger, J. Gan, E. Bachar-Lustig, and Y. Reisner
Tolerance Induction by Veto CTLs in the TCR Transgenic 2C Mouse Model. II. Deletion of Effector Cells by Fas-Fas Ligand Apoptosis
J. Immunol., December 1, 2004; 173(11): 6660 - 6666.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. T. Stock, S. N. Mueller, A. L. van Lint, W. R. Heath, and F. R. Carbone
Cutting Edge: Prolonged Antigen Presentation after Herpes Simplex Virus-1 Skin Infection
J. Immunol., August 15, 2004; 173(4): 2241 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Moroz, C. Eppolito, Q. Li, J. Tao, C. H. Clegg, and P. A. Shrikant
IL-21 Enhances and Sustains CD8+ T Cell Responses to Achieve Durable Tumor Immunity: Comparative Evaluation of IL-2, IL-15, and IL-21
J. Immunol., July 15, 2004; 173(2): 900 - 909.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. L. Salem, A. N. Kadima, Y. Zhou, C. L. Nguyen, M. P. Rubinstein, M. Demcheva, J. N. Vournakis, D. J. Cole, and W. E. Gillanders
Paracrine Release of IL-12 Stimulates IFN-{gamma} Production and Dramatically Enhances the Antigen-Specific T Cell Response after Vaccination with a Novel Peptide-Based Cancer Vaccine
J. Immunol., May 1, 2004; 172(9): 5159 - 5167.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. L. Ahonen, C. L. Doxsee, S. M. McGurran, T. R. Riter, W. F. Wade, R. J. Barth, J. P. Vasilakos, R. J. Noelle, and R. M. Kedl
Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN
J. Exp. Med., March 15, 2004; 199(6): 775 - 784.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Chang, J.-H. Cho, S.-W. Lee, S.-Y. Choi, S.-J. Ha, and Y.-C. Sung
IL-12 Priming during In Vitro Antigenic Stimulation Changes Properties of CD8 T Cells and Increases Generation of Effector and Memory Cells
J. Immunol., March 1, 2004; 172(5): 2818 - 2826.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Curtsinger, C. M. Johnson, and M. F. Mescher
CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine
J. Immunol., November 15, 2003; 171(10): 5165 - 5171.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H. Beacock-Sharp, A. M. Donachie, N. C. Robson, and A. M. Mowat
A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo
Int. Immunol., June 1, 2003; 15(6): 711 - 720.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott
Archaeosomes Induce Enhanced Cytotoxic T Lymphocyte Responses to Entrapped Soluble Protein in the Absence of Interleukin 12 and Protect against Tumor Challenge
Cancer Res., May 15, 2003; 63(10): 2526 - 2534.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
J. M. Curtsinger, D. C. Lins, and M. F. Mescher
Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function
J. Exp. Med., May 5, 2003; 197(9): 1141 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. W. Lee, Y. Park, J. K. Yoo, S. Y. Choi, and Y. C. Sung
Inhibition of TCR-Induced CD8 T Cell Death by IL-12: Regulation of Fas Ligand and Cellular FLIP Expression and Caspase Activation by IL-12
J. Immunol., March 1, 2003; 170(5): 2456 - 2460.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Goldberg, P. Shrikant, and M. F. Mescher
In Vivo Augmentation of Tumor-Specific CTL Responses by Class I/Peptide Antigen Complexes on Microspheres (Large Multivalent Immunogen)
J. Immunol., January 1, 2003; 170(1): 228 - 235.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Valenzuela, C. Schmidt, and M. Mescher
The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells
J. Immunol., December 15, 2002; 169(12): 6842 - 6849.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. A. E. Harmala, E. G. Ingulli, J. M. Curtsinger, M. M. Lucido, C. S. Schmidt, B. J. Weigel, B. R. Blazar, M. F. Mescher, and C. A. Pennell
The Adjuvant Effects of Mycobacterium tuberculosis Heat Shock Protein 70 Result from the Rapid and Prolonged Activation of Antigen-Specific CD8+ T Cells In Vivo
J. Immunol., November 15, 2002; 169(10): 5622 - 5629.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
J. Hernandez, S. Aung, K. Marquardt, and L. A. Sherman
Uncoupling of Proliferative Potential and Gain of Effector Function by CD8+ T Cells Responding to Self-Antigens
J. Exp. Med., August 5, 2002; 196(3): 323 - 333.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. S. Schmidt and M. F. Mescher
Peptide Antigen Priming of Naive, But Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-12
J. Immunol., June 1, 2002; 168(11): 5521 - 5529.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. D. Higgins, M. A. Mihalyo, P. W. McGary, and A. J. Adler
CD4 Cell Priming and Tolerization Are Differentially Programmed by APCs upon Initial Engagement
J. Immunol., June 1, 2002; 168(11): 5573 - 5581.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Gong, S. Koido, D. Chen, Y. Tanaka, L. Huang, D. Avigan, K. Anderson, T. Ohno, and D. Kufe
Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
Blood, April 1, 2002; 99(7): 2512 - 2517.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G.-X. Zhang, H. Xu, M. Kishi, D. Calida, and A. Rostami
The Role of IL-12 in the Induction of Intravenous Tolerance in Experimental Autoimmune Encephalomyelitis
J. Immunol., March 1, 2002; 168(5): 2501 - 2507.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Lee, F. Wang, J. Kuniyoshi, V. Rubio, T. Stuges, S. Groshen, C. Gee, R. Lau, G. Jeffery, K. Margolin, et al.
Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma
J. Clin. Oncol., September 15, 2001; 19(18): 3836 - 3847.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. M. Kedl, M. Jordan, T. Potter, J. Kappler, P. Marrack, and S. Dow
CD40 stimulation accelerates deletion of tumor-specific CD8+ T cells in the absence of tumor-antigen vaccination
PNAS, August 23, 2001; (2001) 191371898.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Stober, R. Schirmbeck, and J. Reimann
IL-12/IL-18-Dependent IFN-{{gamma}} Release by Murine Dendritic Cells
J. Immunol., July 15, 2001; 167(2): 957 - 965.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. C. Kieper, M. Prlic, C. S. Schmidt, M. F. Mescher, and S. C. Jameson
IL-12 Enhances CD8 T Cell Homeostatic Expansion
J. Immunol., May 1, 2001; 166(9): 5515 - 5521.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. J. Roy, U. Gawlick, B. A. Orr, L. A. Rund, A. G. Webb, and D. M. Kranz
IL-12 Treatment of Endogenously Arising Murine Brain Tumors
J. Immunol., December 15, 2000; 165(12): 7293 - 7299.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Koido, M. Kashiwaba, D. Chen, S. Gendler, D. Kufe, and J. Gong
Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA
J. Immunol., November 15, 2000; 165(10): 5713 - 5719.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. J. Mosca, A. C. Hobeika, T. M. Clay, S. K. Nair, E. K. Thomas, M. A. Morse, and H. K. Lyerly
A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment
Blood, November 15, 2000; 96(10): 3499 - 3504.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. J. Skinner, M. A. Daniels, C. S. Schmidt, S. C. Jameson, and A. T. Haase
Cutting Edge: In Situ Tetramer Staining of Antigen-Specific T Cells in Tissues
J. Immunol., July 15, 2000; 165(2): 613 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. M. Kedl, M. Jordan, T. Potter, J. Kappler, P. Marrack, and S. Dow
CD40 stimulation accelerates deletion of tumor-specific CD8+ T cells in the absence of tumor-antigen vaccination
PNAS, September 11, 2001; 98(19): 10811 - 10816.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.